Monday, April 10, 2017 6:12:45 PM
Yes, I certainly always tried to accompany my PPS guesses due to reasoning.
The fact that we ran to $3.23 on February 23rd was kind of stupid. What happened? They announced they were going to a conference that we all knew about for at least a month. Oh, and, we were listed on the pending AgroSphere ETF. Maybe that was the driving factor since CNBX ran big time that same day and they too were included.
So, if we can run to $3.23 for something like that... But can't run to $3.23+ after we announce a possible partnership with Big Pharma, phenomenal study results, a new Executive (formery from Big Pharma), and a new/big distribution deal... (Who knows what's all coming)... Why NOT $3.23+ again?
I've said before... AstraZeneca sold their SUICIDE PROVOKING Psoriasis drug for $445 MILLION in 2015. If OWCP proves to have a better product with little to no side effects... Why can't our market cap reach $500,000,000?
That's ~$3.33/share.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM